Evidence map›Paper›PMID 42620482›Full record

ArticlemedRxiv : the preprint server for health sciences2026

BioDeformUNet: A Deep Learning Model for Biomechanically Informed Liver Image Registration.

Xinyue Zhang, Caleb S O'Connor, Austin Castelo, McKell E Woodland, Bilel Daoud, Iwan Paolucci, Jessica Albuquerque, Mais Altaie, Noreen Siddiqi, Ankit B Patel and 2 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xinyue ZhangThe University of Texas MD Anderson Cancer Center; Rice University, 1515 Holcombe Blvd, Houston, TX 77030.
Caleb S O'ConnorThe University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030.
Austin CasteloThe University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030.ORCID 0009-0009-3015-3570
McKell E WoodlandThe University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030.
Bilel DaoudThe University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030.
Iwan PaolucciThe University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030.
Jessica AlbuquerqueThe University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030.
Mais AltaieThe University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030.
Noreen SiddiqiThe University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030.
Ankit B PatelBaylor College of Medicine. Rice University.
Bruno C OdisioThe University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030.
Kristy K BrockThe University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
Anatomical Modeling to Improve the Precision of Image Guided Liver AblationR01CA235564 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BROCK, KRISTY, ODISIO, BRUNO C · 2019 to 2023
$1.7M
Image Guided Cancer Therapy Training ProgramT32CA261856 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Kristy Brock, Clifton David Fuller · 2022 to 2026
$1.2M
NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA235564NCI NIH HHS T32 CA261856
6 · The paper itself

Abstract

Purpose: To build a 3D U-Net model, BioDeformUNet, to predict the liver's deformation vector field (DVF) in near real-time, for efficient intra-procedural evaluation of the minimal ablative margin (MAM). Materials and Methods: This retrospective study included 170 contrast-enhanced computed tomography (CECT) image pairs from 157 patients who underwent liver ablation treatment between 2020-2024. Each data instance included one pre-ablation CECT (pre-CECT) and one post-ablation CECT (post-CECT). BioDeformUNet was trained under the guidance of DVFs generated by a biomechanical model-based deformable image registration (DIR) algorithm using a loss function that focused on large liver deformations. Data were split patient-wise into training (92-93 patients), validation (23-24 patients), and testing sets (42 patients). We compared our method's performance with two deep learning-based DIR methods: VoxelMorph and VFA. Evaluation metrics included: target registration error (TRE), Dice similarity coefficient (DSC), Minimum Ablation Margin (MAM), and inference time. For BioDeformUNet, we additionally evaluated the accuracy of the deformed tumor center-of-mass mapping by comparing the predicted tumor center location with that generated by Morfeus. A mapping error less than 3.0 mm (corresponding to the voxel size) was considered accurate. We used the Wilcoxon signed-rank test to assess the significancy of each test result. Our code is available at https://github.com/XinyueZhang831/BioDeformUNET. Results: The TRE of BioDeformUNet was not significantly different from Morfeus (3.31±1.17 BioDeformUNet; 3.23±1.06 Morfeus; p-value=0.41). The BioDeformUNet DVF magnitude was within 3.0 mm of Morfeus DVF for an average of 91.9 ± 17.6% (mean ± SD) of the voxels. Tumor mapping errors greater than 3.0 mm occurred in only 8 cases. The inference time of BioDeformUNet was 0.6s per image pair, 0.2s for VoxelMorph, 0.3s for VFA, and 20.2s for Morfeus. Conclusion: BioDeformUNet achieved a similar performance to the biomechanical model-based algorithm but required fewer computational operations, resulting in a 34× speedup in DVF computation.

Identifiers

PMID42620482
PMCPMC13484791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.